Shenzhen Chipscreen Biosciences Co., Ltd.
SSE:688321.SS
22.9 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -114.571 | 88.839 | 12.816 | 21.958 | 31.046 | 19.422 | 31.165 | 24.074 | 5.244 |
| Depreciation & Amortization
| 59.034 | 45.622 | 38.725 | 19.621 | 11.068 | 4.81 | 4.339 | 4.379 | 3.71 |
| Deferred Income Tax
| 0 | 0 | -2.637 | -18.698 | -1.647 | -0.539 | -0.729 | -0.417 | 0 |
| Stock Based Compensation
| 0 | 0.322 | 14.935 | 35.378 | 15.091 | 0.539 | 0 | 0 | 0 |
| Change In Working Capital
| 5.809 | -38.036 | -21.866 | 89.357 | 67.532 | -38.175 | -8.187 | -23.321 | 54.443 |
| Accounts Receivables
| -19.617 | -59.115 | -42.459 | -73.725 | 50.224 | -37.205 | -20.901 | -23.304 | -1.185 |
| Inventory
| 6.286 | -18.655 | -19.406 | -1.104 | -1.419 | -2.522 | 0.723 | -5.407 | -2.214 |
| Accounts Payables
| 0 | 49.754 | 42.636 | 182.885 | 20.374 | 2.09 | 12.72 | 5.807 | 57.843 |
| Other Working Capital
| 19.141 | -10.019 | -2.637 | -18.698 | -1.647 | -0.539 | -8.91 | -17.914 | 56.658 |
| Other Non Cash Items
| 125.856 | -239.958 | 1.324 | -22.832 | -29.471 | -10.61 | -4.534 | -2.402 | -3.63 |
| Operating Cash Flow
| 76.128 | -143.211 | 43.296 | 124.783 | 93.619 | -24.553 | 22.783 | 2.73 | 59.768 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -268.487 | -229.029 | -400.168 | -288.465 | -336.269 | -133.023 | -140.74 | -132.825 | -65.809 |
| Acquisitions Net
| 0 | 0 | 108.536 | 0.015 | 336.274 | 133.048 | 0.006 | 0.074 | 0.001 |
| Purchases Of Investments
| -1,403.63 | -1,275.384 | -1,047.455 | -657 | -1,534.961 | -821.057 | -305.6 | -1,071.5 | -330 |
| Sales Maturities Of Investments
| 1,376.08 | 1,170.306 | 645.633 | 914.826 | 1,762.53 | 232.58 | 433 | 1,008.159 | 260.21 |
| Other Investing Activites
| 0.004 | -54.962 | -108.25 | 0 | -336.269 | -133.023 | 0 | 0 | 0 |
| Investing Cash Flow
| -296.034 | -389.069 | -801.704 | -30.624 | -108.694 | -721.476 | -13.334 | -196.091 | -135.598 |
| Financing Activities: | |||||||||
| Debt Repayment
| 221.826 | 226.789 | 283.32 | 84.864 | -42.096 | 6.5 | 18.5 | -21.201 | 46.201 |
| Common Stock Issued
| 0 | 0 | 3.803 | 155.477 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -3.803 | -155.477 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -27.628 | -18.743 | -12.167 | -4.225 | -3.279 | -1.485 | -0.55 | -2.322 | -3.493 |
| Other Financing Activities
| -18.835 | 174.571 | 590.135 | 10.637 | -0 | 946.673 | -0.55 | 215.734 | 98.888 |
| Financing Cash Flow
| 175.363 | 382.617 | 861.288 | -63.315 | -45.375 | 950.203 | 17.95 | 192.211 | 141.596 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.394 | 1.083 | 12.231 | -2.247 | -4.082 | 0.646 | 1.365 | -2.277 | 2.37 |
| Net Change In Cash
| -44.149 | -148.579 | 115.111 | 28.597 | -64.531 | 204.82 | 28.763 | -3.427 | 68.136 |
| Cash At End Of Period
| 222.54 | 266.689 | 415.268 | 300.157 | 271.56 | 336.091 | 131.271 | 102.508 | 105.935 |